Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) announced it was named to Fortune's 2026 World's Most Admired Companies list for the 12th consecutive year and ranked #2 in the "Health Care: Pharmacy and Other Services" industry category.

The recognition is based on nine corporate‑reputation attributes surveyed by Korn Ferry and Fortune, covering product quality, innovation, long‑term value, financial profile, responsibility, and people management. Quest highlighted its 55,000 colleagues and role delivering diagnostic insights from one of the largest de‑identified clinical lab databases, serving roughly one in three U.S. adults annually.

News Market Reaction – DGX

-2.28%

-2.28% Session close to close

In the Jan 21 session, DGX declined 2.28%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECAUCUS, N.J., Jan. 21, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been named to the Fortune^® magazine 2026 World's Most Admired Companies™ list, for the 12^th consecutive year.

"Quest's recognition as one of the world's most admired companies reflects the commitment of our 55,000 colleagues to living our purpose every day: working together to create a healthier world, one life at a time," said Jim Davis, Chairman, CEO and President. "We are proud to again be named among this elite list of globally respected companies and even more proud to continue our important work at the center of healthcare, delivering diagnostic insights that illuminate a path to better health."

In addition to the overall ranking, Quest ranked number two in the "Health Care: Pharmacy and Other Services" industry category.

Fortune's World's Most Admired recognition is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, long-term value and financial profile, social, environmental and community responsibility, and people management. Consulting firm Korn Ferry collaborated with Fortune to survey thousands of executives, directors and analysts who rated companies in their industry, analyzing nearly 700 companies. A company's score must rank in the top half of its industry survey to be listed as a World's Most Admired Company.

Find more information on the 2026 Fortune's World's Most Admired Companies here.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-named-to-fortunes-worlds-most-admired-companies-list-for-12th-consecutive-year-302667159.html

SOURCE Quest Diagnostics

FAQ

What recognition did Quest Diagnostics (DGX) receive on January 21, 2026?

Quest Diagnostics was named to Fortune's 2026 World's Most Admired Companies list for the 12th consecutive year and ranked #2 in its industry category.

How does Fortune determine the World's Most Admired Companies that include DGX?

Fortune and Korn Ferry survey thousands of executives, directors, and analysts who rate companies on nine reputation attributes such as product quality, innovation, and people management.

Why is the Fortune recognition notable for Quest Diagnostics (DGX)?

The listing reflects repeated external recognition of Quest's reputation across quality, innovation, financial profile, and social responsibility and its position in healthcare diagnostics.

What industry ranking did Quest Diagnostics (DGX) achieve on the 2026 list?

Quest ranked #2 in the "Health Care: Pharmacy and Other Services" industry category on the 2026 list.

How large is Quest Diagnostics' workforce as cited in the January 21, 2026 announcement?

The company cited a workforce of approximately 55,000 colleagues in the announcement.

Does the Fortune recognition reference Quest Diagnostics' clinical data resources?

Yes; the announcement highlights diagnostic insights derived from one of the world's largest de‑identified clinical lab result databases.